Biotest Investor Relations Material

Biotest Aktiengesellschaft is a German-based company that specializes in the development, production, and marketing of plasma proteins and biological drugs. The company’s primary focus areas include clinical immunology, hematology, and intensive care medicine. Biotest’s product portfolio includes immunoglobulins, coagulation factors, and albumins, which are derived from human blood plasma and are utilized in treating immune and hematopoietic system disorders. Additionally, the company engages in the development of monoclonal antibodies for treating conditions such as cancer of plasma cells and systemic lupus erythematosus. The company is headquartered in Dreieich, Germany, and its shares are listed on the Frankfurt Stock Exchange.